Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial.


Journal

Molecular nutrition & food research
ISSN: 1613-4133
Titre abrégé: Mol Nutr Food Res
Pays: Germany
ID NLM: 101231818

Informations de publication

Date de publication:
04 2021
Historique:
revised: 21 01 2021
received: 09 12 2020
pubmed: 26 2 2021
medline: 20 11 2021
entrez: 25 2 2021
Statut: ppublish

Résumé

Xanthohumol, a prenylflavonoid from hops, has been extensively studied preclinically but has undergone limited research in human subjects. A triple-masked, placebo-controlled phase I clinical trial was conducted to examine the safety and tolerability of xanthohumol. Thirty healthy volunteers were randomized to 24 mg day Over an eight-week period, 24 mg daily xanthohumol was safe and well-tolerated by healthy adults.

Identifiants

pubmed: 33629812
doi: 10.1002/mnfr.202001170
pmc: PMC8221389
mid: NIHMS1707595
doi:

Substances chimiques

Biomarkers 0
Flavonoids 0
Placebos 0
Propiophenones 0
xanthohumol T4467YT1NT

Types de publication

Clinical Trial, Phase I Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2001170

Subventions

Organisme : NCCIH NIH HHS
ID : K24 AT011568
Pays : United States
Organisme : NCCIH NIH HHS
ID : R01 AT010271
Pays : United States

Informations de copyright

© 2021 Wiley-VCH GmbH.

Références

Glob Adv Health Med. 2019 Jul 29;8:2164956119867251
pubmed: 31384513
Mol Nutr Food Res. 2014 Oct;58(10):1962-9
pubmed: 25045111
Nutrients. 2018 Jan 04;10(1):
pubmed: 29300341
ACR Open Rheumatol. 2020 Jun;2(6):320-329
pubmed: 32386128
Clin Ther. 2018 May;40(5):672-673
pubmed: 29703431
Mol Nutr Food Res. 2016 Apr;60(4):773-86
pubmed: 26840505
J Agric Food Chem. 2000 Sep;48(9):3876-84
pubmed: 10995285
Mol Nutr Food Res. 2005 Sep;49(9):821-3
pubmed: 16144029
Mol Nutr Food Res. 2018 Mar;62(6):e1700692
pubmed: 29322620
Arthritis Care Res (Hoboken). 2017 Sep;69(9):1312-1321
pubmed: 28029753
J Chromatogr A. 1999 Feb 5;832(1-2):97-107
pubmed: 10070768
Mol Nutr Food Res. 2014 Feb;58(2):248-55
pubmed: 24038952
Sci Rep. 2018 Jan 12;8(1):613
pubmed: 29330372
J Clin Epidemiol. 2016 May;73:89-102
pubmed: 26952842
Qual Life Res. 2018 Jul;27(7):1885-1891
pubmed: 29569016
N Engl J Med. 2011 Jul 7;365(1):3-5
pubmed: 21651388
J Agric Food Chem. 2005 Aug 10;53(16):6281-8
pubmed: 16076107
Trials. 2020 Oct 7;21(1):835
pubmed: 33028396
Drug Test Anal. 2016 Mar-Apr;8(3-4):271-82
pubmed: 26593452
Mol Nutr Food Res. 2020 Jan;64(1):e1900789
pubmed: 31755244
Phytochem Rev. 2016 Jun;15(3):425-444
pubmed: 27274718
Food Chem Toxicol. 2018 Aug;118:963-971
pubmed: 29626579
J Nutr. 2006 Jul;136(7):1862-7
pubmed: 16772450

Auteurs

Blake O Langley (BO)

Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, USA.

Jennifer Joan Ryan (JJ)

Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, USA.

Douglas Hanes (D)

Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, USA.

John Phipps (J)

Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, USA.

Emily Stack (E)

Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, USA.

Thomas O Metz (TO)

Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA.

J Frederik Stevens (JF)

College of Pharmacy and the Linus Pauling Institute, Oregon State University, Corvallis, Oregon, USA.

Ryan Bradley (R)

Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, USA.
Herbert Wertheim School of Public Health and Human Longevity Science, San Diego, University of California, La Jolla, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH